Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Thrombosis

indazoles has been researched along with Thrombosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, N; Hamano, I; Hashimoto, Y; Hatakeyama, S; Hosogoe, S; Iwamura, H; Koie, T; Kusaka, A; Ohyama, C; Tanaka, T; Tanaka, Y; Tobisawa, Y; Yamamoto, H; Yoneyama, T1
Arunachalam, P; Barbera, FA; Bisacchi, GS; Bozarth, JM; Corte, JR; Fang, T; Friends, TJ; Hangeland, JJ; Luettgen, JM; Mathur, A; Morin, PE; Quan, ML; Ramamurthy, V; Rendina, AR; Rossi, KA; Seiffert, DA; Smallheer, JM; Subramaniam, S; Sun, Z; Wang, C; Watson, CA; Wei, A; Wexler, RR; Wong, PC; Zhang, G1
Jiang, C; Li, J; Lian, M; Ma, C; Shen, T; Shi, J; Wang, N; Wei, L; Yu, X; Zhang, C; Zhao, X; Zhu, D1
Addo, MF; Andrade-Gordon, P; D'Andrea, MR; Damiano, BP; Darrow, AL; Derian, CK; Maryanoff, BE; Nedelman, M; Zhang, HC1
Cwiklicki, A; Rehse, K1
Bischoff, E; Rehse, K; Stasch, JP; Yildiz, AK1
Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC1
Addo, MF; Andrade-Gordon, P; D'Andrea, MR; Damiano, BP; Darrow, AL; de Garavilla, L; Derian, CK; Eckardt, AJ; Giardino, EC; Haertlein, BJ; Maryanoff, BE; McComsey, DF; Zhang, HC1
Bologna, E1

Trials

1 trial(s) available for indazoles and Thrombosis

ArticleYear
Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.
    International journal of clinical oncology, 2018, Volume: 23, Issue:1

    Topics: Aged; Axitinib; Blood Loss, Surgical; Carcinoma, Renal Cell; Female; Fibrosis; Humans; Imidazoles; Indazoles; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Postoperative Complications; Preoperative Care; Retrospective Studies; Thrombosis; Vena Cava, Inferior; Venous Thrombosis

2018

Other Studies

8 other study(ies) available for indazoles and Thrombosis

ArticleYear
Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity.
    Journal of medicinal chemistry, 2014, Dec-11, Volume: 57, Issue:23

    Topics: Animals; Crystallography, X-Ray; Fibrinolytic Agents; Humans; Imidazoles; Indazoles; Models, Molecular; Partial Thromboplastin Time; Rabbits; Thrombosis

2014
15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Sep-01, Volume: 309, Issue:5

    Topics: Animals; Arachidonate 15-Lipoxygenase; Blood Platelets; Cells, Cultured; Chemokine CCL2; Cytokines; Humans; Hydroxyeicosatetraenoic Acids; Hypertension, Pulmonary; Hypoxia; Indazoles; Lipoxygenase Inhibitors; Male; Masoprocol; Platelet Activation; Propionates; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; RNA Interference; RNA, Small Interfering; Signal Transduction; Thrombosis; Vascular Resistance

2015
Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:2

    Topics: Animals; Carotid Artery, Common; Female; Indazoles; Macaca fascicularis; Male; Platelet Aggregation; Receptor, PAR-1; Receptors, Thrombin; Thrombosis; Urea

2003
Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Archiv der Pharmazie, 2004, Volume: 337, Issue:3

    Topics: Animals; Fibrinolytic Agents; Guanylate Cyclase; Indazoles; Lasers; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Triazoles

2004
New antithrombotics with an indazole structure.
    Archiv der Pharmazie, 2004, Volume: 337, Issue:6

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Enzyme Activation; Fibrinolytic Agents; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombosis

2004
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Disease Models, Animal; Enzyme Activation; Fibrinolytic Agents; Fluorescein; Fluoresceins; Guanylate Cyclase; Indazoles; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Serum Globulins; Solubility; Thrombosis

1997
Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1

    Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Cell Culture Techniques; Graft Occlusion, Vascular; Guinea Pigs; Humans; Indazoles; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Receptors, Thrombin; Thrombosis; Urea

2001
Influence of some drugs on platelet aggregation: a study in hypertensive patients.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 52

    Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Blood Cell Count; Blood Coagulation; Blood Platelets; Dimethylamines; Dipyridamole; Humans; Hypertension; In Vitro Techniques; Indazoles; Indomethacin; Phenylbutazone; Platelet Adhesiveness; Reserpine; Thrombosis; Time Factors

1972